Abivax Shares Plunge Over 43% on Cancer Cases in Bowel Disease Drug Trial
Summary: French biotech firm Abivax saw its stock plummet over...
Source bias
Political lean of the 1 rated outlet covering this story: Center 1.
Sources on this story
Reported by 1 sources, including:
- CNBC